AAAAAA
Results:
1-10
|
Results: 10
Authors:
Belldegrun, A
Tso, CL
Zisman, A
Naitoh, J
Said, J
Pantuck, AJ
Hinkel, A
de Kernion, J
Figlin, R
Citation: A. Belldegrun et al., Interleukin 2 gene therapy for prostate cancer: Phase I clinical trial andbasic biology, HUM GENE TH, 12(8), 2001, pp. 883-892
Authors:
Tso, CL
Zisman, A
Pantuck, A
Calilliw, R
Hernandez, JM
Paik, S
Nguyen, D
Gitlitz, B
Shintaku, PI
de Kernion, S
Figlin, R
Belldegrun, A
Citation: Cl. Tso et al., Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 andGranulocyte/Monocyte-Colony stimulating factor, CANCER RES, 61(21), 2001, pp. 7925-7933
Authors:
Hinkel, A
Tso, CL
Gitlitz, BJ
Neagos, N
Schmid, I
Paik, SH
deKernion, J
Figlin, R
Belldegrun, A
Citation: A. Hinkel et al., Immunomodulatory dendritic cells generated from nonfractionated bulk peripheral blood mononuclear cell cultures induce growth of cytotoxic T cells against renal cell carcinoma, J IMMUNOTH, 23(1), 2000, pp. 83-93
Authors:
Small, EJ
Figlin, R
Petrylak, D
Vaughn, DJ
Sartor, O
Horak, I
Pincus, R
Kremer, A
Bowden, C
Citation: Ej. Small et al., A phase II pilot study of KW-2189 in patients with advanced renal cell carcinoma, INV NEW DR, 18(2), 2000, pp. 193-197
Authors:
Tsui, KH
Shvarts, O
Smith, RB
Figlin, R
DeKernion, JB
Belldegrun, A
Citation: Kh. Tsui et al., Renal cell carcinoma: Prognostic significance of incidentally detected tumors, J UROL, 163(2), 2000, pp. 426-430
Authors:
Tsui, KH
Shvarts, O
Barbaric, Z
Figlin, R
DeKernion, JB
Belldegrun, A
Citation: Kh. Tsui et al., Is adrenalectomy a necessary component of radical nephrectomy? UCLA experience with 511 radical nephrectomies, J UROL, 163(2), 2000, pp. 437-441
Authors:
Mulders, P
Tso, CL
Gitlitz, B
Kaboo, R
Hinkel, A
Frand, S
Kiertscher, S
Roth, MD
deKernion, J
Figlin, R
Belldegrun, A
Citation: P. Mulders et al., Presentation of renal tumor antigens by human dendritic cells activates tumor-infiltrating lymphocytes against autologous tumor: Implications for live kidney cancer vaccines, CLIN CANC R, 5(2), 1999, pp. 445-454
Authors:
Cangiano, T
Liao, J
Naitoh, J
Dorey, F
Figlin, R
Belldegrun, A
Citation: T. Cangiano et al., Sarcomatoid renal cell carcinoma: Biologic behavior, prognosis, and response to combined surgical resection and immunotherapy, J CL ONCOL, 17(2), 1999, pp. 523-528
Authors:
Figlin, R
Citation: R. Figlin, Serum C-reactive protein level and the impact of cytoreductive surgery in patients with metastatic renal cell carcinoma. Comment, J UROL, 162(6), 1999, pp. 1937-1937
Authors:
Naitoh, J
Kaplan, A
Dorey, F
Figlin, R
Belldegrun, A
Citation: J. Naitoh et al., Metastatic renal cell carcinoma with concurrent inferior vena caval invasion: Long-term survival after combination therapy with radical nephrectomy, vena caval thrombectomy and postoperative immunotherapy, J UROL, 162(1), 1999, pp. 46-50
Risultati:
1-10
|